IMRT Best for Locally Advanced NSCLC, Study Suggests
SINGAPORE — Intensity-modulated radiation therapy (IMRT) should be the radiation technique of choice for unresectable locally advanced non-small lung cancer (NSCLC), a secondary analysis of a randomized trial suggested. In the study, IMRT resulted in similar survival outcomes compared with 3D conformal radiotherapy (3D-CRT), but with less severe lung toxicity and radiation exposure to the […]
Long-Acting Injection Preferred Over Daily Pills for PrEP
BRISBANE, Australia – When given a choice for pre-exposure prophylaxis (PrEP) to prevent infection with HIV, women preferred injectable cabotegravir (Apretude) every 2 months rather than an oral pill daily, researchers reported here. About 78% of women enrolled in the landmark HPTN 084 trial said they preferred the injection over taking the pills, said Mina […]
39 Super Useful Items Reviewers Say ‘Never Fail’
Amazon Paula’s Choice face wash, Carpet Miracle and One Hit Wonder 10-in-1 leave-in spray. Popular products from this list: Paula’s Choice Skin Perfecting 2% BHA liquid exfoliant because it’s top-rated for providing awesome results in smoothing and clearing skin Sunny & Honey Carpet Miracle cleaner for those stains you’d never thought would come out A […]
Vote: MedPage Today Readers’ Choice Awards
You are invited to submit your votes for the 2022 MedPage Today Readers’ Choice Awards! These awards highlight excellence in medicine across multiple platforms, all nominated by our readers along with MedPage Today‘s staff and editorial board. Voting ends Dec. 23, 2022 Please enable JavaScript to view the comments powered by Disqus.
Bictegravir-Based Treatment Wins for HIV/HBV Co-Infections
MONTREAL — For individuals infected by both HIV and hepatitis B virus (HBV), the choice of which virus-suppressing therapy to use can make a difference in outcomes, according to 48-week results of the phase III ALLIANCE results reported here. In a head-to-head comparison, fixed doses of either bictegravir, emtricitabine, and tenofovir alafenamide (Biktarvy) or dolutegravir, […]